Compared with IDH-wild-type, 1p19q non-codeletion, and recurrent subtypes, the expression of SMOC1 was increased in IDH mutant, 1p19q co-deletion, and primary gliomas. This evidence concerns the gene SMOC1 and central nervous system cancer.